1

================================================================================


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 10-Q


   (Mark One)

   [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities
       Exchange Act of 1934 for the quarterly period ended JULY 1, 2001 or

   [ ] Transition  Report  pursuant to Section 13 or 15(d) of the Securities
       Exchange  Act of 1934 for the  transition period from _______ to ________


                         COMMISSION FILE NUMBER 0-17869
                                                -------


                               COGNEX CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         MASSACHUSETTS                                          04-2713778
- -------------------------------                             -------------------
(State or other jurisdiction of                              (I.R.S. Employer
 incorporation or organization)                              Identification No.)



                                ONE VISION DRIVE
                        NATICK, MASSACHUSETTS 01760-2059
                                 (508) 650-3000
              ----------------------------------------------------
               (Address, including zip code, and telephone number,
              including area code, of principal executive offices)


     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                  Yes    X               No
                        ---                  ---

     As of July 29, 2001, there were 43,633,382 shares of Common Stock, $.002
par value, of the registrant outstanding.


                            Total number of pages: 12
                       Exhibit index is located on page 11

================================================================================

   2


                                      INDEX


PART I    FINANCIAL INFORMATION

Item 1.   Financial Statements

          Consolidated Statements of Income for the three and six months ended
            July 1, 2001 and July 2, 2000
          Consolidated Balance Sheets at July 1, 2001 and December 31, 2000
          Consolidated Statement of Stockholders' Equity for the six months
            ended July 1, 2001
          Consolidated Condensed Statements of Cash Flows for the six months
            ended July 1, 2001 and July 2, 2000
          Notes to Consolidated Financial Statements

Item 2.   Management's Discussion and Analysis of Financial Condition and
            Results of Operations

PART II   OTHER INFORMATION

Item 1.   Legal Proceedings

Item 2.   Changes in Securities

Item 3.   Defaults Upon Senior Securities

Item 4.   Submission of Matters to a Vote of Security Holders

Item 5.   Other Information

Item 6.   Exhibits and Reports on Form 8-K

          Signatures

   3


                          PART I: FINANCIAL INFORMATION

ITEM 1:  FINANCIAL STATEMENTS


                               COGNEX CORPORATION
                        CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands, except per share amounts)



                                                       THREE MONTHS ENDED          SIX MONTHS ENDED
                                                      JULY 1,       JULY 2,       JULY 1,        JULY 2,
                                                       2001          2000          2001          2000
                                                     --------      --------      --------      --------
                                                            (UNAUDITED)             (UNAUDITED)

                                                                                   
Revenue .........................................    $ 37,379      $ 62,187      $ 81,585      $116,682

Cost of revenue .................................      12,251        16,160        25,043        30,078
                                                     --------      --------      --------      --------

Gross profit ....................................      25,128        46,027        56,542        86,604

Research, development, and engineering expenses..       7,655         8,083        15,837        15,366

Selling, general, and administrative expenses ...      16,441        14,593        34,879        27,170

Amortization of goodwill ........................         778           553         1,555           644
                                                     --------      --------      --------      --------

Operating income ................................         254        22,798         4,271        43,424

Investment income ...............................       2,766         2,486         5,484         4,307

Other income ....................................         149           243           416           461
                                                     --------      --------      --------      --------

Income before provision for income taxes ........       3,169        25,527        10,171        48,192

Provision for income taxes ......................       1,014         8,169         3,255        15,422
                                                     --------      --------      --------      --------

Net income ......................................    $  2,155      $ 17,358      $  6,916      $ 32,770
                                                     ========      ========      ========      ========

Net income per share:
    Basic .......................................    $    .05      $    .40      $    .16      $    .77
                                                     ========      ========      ========      ========
    Diluted .....................................    $    .05      $    .38      $    .15      $    .71
                                                     ========      ========      ========      ========


Weighted-average common and common equivalent
    shares outstanding:
    Basic .......................................      43,545        43,067        43,504        42,735
                                                     ========      ========      ========      ========
    Diluted .....................................      45,442        46,159        45,177        45,845
                                                     ========      ========      ========      ========





              The accompanying notes are an integral part of these
                       consolidated financial statements.

                                       1

   4


                               COGNEX CORPORATION

                           CONSOLIDATED BALANCE SHEETS
                             (Dollars in thousands)



                                                                                JULY 1,       DECEMBER 31,
                                                                                  2001           2000
                                                                               ---------      ------------
ASSETS                                                                        (UNAUDITED)
                                                                                         
Current assets:
     Cash and cash equivalents ..............................................  $  47,612       $  42,925
     Short-term investments .................................................    109,900          85,429
     Accounts receivable, less reserves of $2,204 and $2,150 in 2001 and
        2000, respectively ..................................................     23,233          47,031
     Inventories ............................................................     35,211          27,664
     Deferred income taxes ..................................................      8,532           7,741
     Prepaid expenses and other current assets ..............................      9,551           8,950
                                                                               ---------       ---------
         Total current assets ...............................................    234,039         219,740

Long-term investments .......................................................    131,775         149,386
Property, plant, and equipment, net .........................................     33,882          34,012
Deferred income taxes .......................................................      7,663           6,903
Other assets ................................................................     23,146          26,100
                                                                               ---------       ---------
                                                                               $ 430,505       $ 436,141
                                                                               =========       =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
     Accounts payable .......................................................  $   4,891       $  10,127
     Accrued expenses .......................................................     15,730          22,953
     Accrued income taxes ...................................................      8,369           9,202
     Customer deposits ......................................................      2,957           3,074
     Deferred revenue .......................................................      6,057           6,471
                                                                               ---------       ---------
         Total current liabilities ..........................................     38,004          51,827
                                                                               ---------       ---------
Other liabilities ...........................................................                        365

Stockholders' equity:
     Common stock, $.002 par value -
        Authorized: 140,000,000 shares, issued: 45,980,694 and 45,787,568
        shares in 2001 and 2000, respectively ...............................         92              92
     Additional paid-in capital .............................................    166,826         163,815
     Treasury stock, at cost, 2,365,242 and 2,365,332 shares in 2001 and
        2000, respectively ..................................................    (42,672)        (42,675)
     Retained earnings ......................................................    272,080         265,164
     Accumulated other comprehensive loss ...................................     (3,825)         (2,447)
                                                                               ---------       ---------
         Total stockholders' equity .........................................    392,501         383,949
                                                                               ---------       ---------
                                                                               $ 430,505       $ 436,141
                                                                               =========       =========



              The accompanying notes are an integral part of these
                       consolidated financial statements.


                                       2

   5
                               COGNEX CORPORATION

                 CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
                             (Dollars in thousands)




                                                                                        ACCUMULATED
                            COMMON STOCK      ADDITIONAL   TREASURY STOCK                 OTHER                            TOTAL
                      ----------------------   PAID-IN    ----------------   RETAINED  COMPREHENSIVE   COMPREHENSIVE   STOCKHOLDERS'
                        SHARES     PAR VALUE   CAPITAL    SHARES     COST    EARNINGS      LOSS            INCOME         EQUITY
                      ----------   ---------  ---------   ------    ------   --------- -------------   -------------   -------------
                                                                                               
Balance at
 December 31, 2000 .. 45,787,568     $92     $163,815   2,365,332  $(42,675)  $265,164    $(2,447)                       $383,949

 Issuance of
  common stock
  under stock
  option and stock
  purchase plans ...     193,126                2,438                                                                       2,438
 Tax benefit from
  exercise of
  stock options ....                              573                                                                         573
 Issuance of
  treasury stock ...                                           (90)        3                                                    3
 Comprehensive
  income:
   Net income ......                                                            6,916                      6,916            6,916
   Unrealized loss
    on investments,
    net of tax .....                                                                       (1,457)        (1,457)          (1,457)
   Foreign currency
    translation
    adjustment .....                                                                           79             79               79
                                                                                                          ------
   Comprehensive
    income .........                                                                                      $5,538
                      ----------     ---     --------   ---------  --------   --------    -------         ======         --------
Balance at July 1,
 2001 (unaudited) ... 45,980,694     $92     $166,826   2,365,242  $(42,672)  $272,080    $(3,825)                       $392,501
                      ==========     ===     ========   =========  ========   ========    =======                        ========



              The accompanying notes are an integral part of these
                       consolidated financial statements.


                                       3

   6

                               COGNEX CORPORATION

                 CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
                             (Dollars in thousands)



                                                                                  SIX MONTHS ENDED
                                                                                 JULY 1,       JULY 2,
                                                                                  2001          2000
                                                                                --------       --------
                                                                                     (UNAUDITED)
                                                                                         
Cash flows from operating activities:
     Net income ..............................................................  $  6,916       $ 32,770
     Adjustments to reconcile net income to net cash provided by operating
       activities:
       Depreciation and amortization .........................................     6,798          5,832
       Tax benefit from exercise of stock options ............................       573         10,000
       Change in current assets and current liabilities ......................       895        (12,728)
       Other                                                                        (909)        (1,072)
                                                                                --------       --------
     Net cash provided by operating activities ...............................    14,273         34,802
                                                                                --------       --------
Cash flows from investing activities:
     Purchase of investments .................................................   (46,345)       (78,458)
     Maturity of investments .................................................    36,015         40,728
     Purchase of property, plant, and equipment ..............................    (3,498)        (4,138)
     Cash paid for business and technology acquisitions,
       net of cash acquired ..................................................      (361)       (11,932)
                                                                                --------       --------
     Net cash used in investing activities ...................................   (14,189)       (53,800)
                                                                                --------       --------
Cash flows from financing activities:
     Issuance of common stock under stock option and stock purchase plans ....     2,441         16,128
                                                                                --------       --------
     Net cash provided by financing activities ...............................     2,441         16,128
                                                                                --------       --------
Effect of exchange rate changes on cash ......................................     2,162            236
                                                                                --------       --------

Net increase (decrease) in cash and cash equivalents .........................     4,687         (2,634)
Cash and cash equivalents at beginning of period .............................    42,925         48,665
                                                                                --------       --------
Cash and cash equivalents at end of period ...................................  $ 47,612       $ 46,031
                                                                                ========       ========






              The accompanying notes are an integral part of these
                       consolidated financial statements.


                                       4

   7


                               COGNEX CORPORATION

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     BASIS OF PRESENTATION

     As permitted by the rules of the Securities and Exchange Commission
     applicable to Quarterly Reports on Form 10-Q, these notes are condensed and
     do not contain all disclosures required by generally accepted accounting
     principles. Reference should be made to the consolidated financial
     statements and related notes included in the Company's Annual Report on
     Form 10-K for the year ended December 31, 2000.

     In the opinion of the management of Cognex Corporation, the accompanying
     consolidated unaudited financial statements contain all adjustments
     (consisting of only normal, recurring adjustments) necessary to present
     fairly the Company's financial position at July 1, 2001, and the results of
     operations for the three and six months ended July 1, 2001 and July 2,
     2000, and changes in stockholders' equity and cash flows for the periods
     presented.

     The results disclosed in the Consolidated Statements of Income for the
     three and six months ended July 1, 2001 are not necessarily indicative of
     the results to be expected for the full year.

     Certain amounts reported in prior periods have been reclassified to be
     consistent with the current period's presentation.



INVENTORIES

Inventories consist of the following:
(In thousands)                                  JULY 1,     DECEMBER 31,
                                                 2001          2000
                                             -----------    ------------
                                             (UNAUDITED)


Raw materials ................................  $20,915      $14,263
Work-in-process ..............................    4,477        5,789
Finished goods ...............................    9,819        7,612
                                                -------      -------
                                                $35,211      $27,664
                                                =======      =======



                                       5
   8


                               COGNEX CORPORATION

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NET INCOME PER SHARE

Net income per share is calculated as follows:



(In thousands)                                                THREE MONTHS ENDED         SIX MONTHS ENDED
                                                              JULY 1,      JULY 2,      JULY 1,      JULY 2,
                                                               2001         2000         2001         2000
                                                              -------      -------      -------      -------
                                                                  (UNAUDITED)               (UNAUDITED)

                                                                                         
Net income................................................... $ 2,155      $17,358      $ 6,916      $32,770
                                                              =======      =======      =======      =======
BASIC:
    Weighted-average common shares outstanding...............  43,545       43,067       43,504       42,735
                                                              =======      =======      =======      =======
    Net income per common share.............................. $   .05      $   .40      $   .16      $   .77
                                                              =======      =======      =======      =======
DILUTED:
    Weighted-average common shares outstanding...............  43,545       43,067       43,504       42,735
    Effect of dilutive securities:
       Stock options.........................................   1,897        3,092        1,673        3,110
                                                              -------      -------      -------      -------
    Weighted-average common and common equivalent shares
       outstanding...........................................  45,442       46,159       45,177       45,845
                                                              =======      =======      =======      =======
    Net income per common and common equivalent share........ $   .05      $   .38      $   .15      $   .71
                                                              =======      =======      =======      =======



FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

In June of 1998, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards (SFAS) No. 133, "Accounting for Derivative
Instruments and Hedging Activities." SFAS No. 133 requires that all derivative
instruments be recorded on the balance sheet at their fair value. Changes in the
fair value of derivatives are recorded each period in current earnings or other
comprehensive income, depending on whether a derivative is designated as part of
a hedge transaction and, if it is, the type of hedge transaction. The Company
adopted the provisions of SFAS No. 133 effective January 1, 2001. The impact of
adopting SFAS No. 133 was immaterial to the Company.

FOREIGN EXCHANGE RISK MANAGEMENT

The Company enters into forward exchange contracts to hedge a portion of its
intercompany sales of inventory by the US parent to the foreign subsidiary
payable in the foreign subsidiary's local currency. These contracts, which
related primarily to the Japanese Yen and Euro, generally have a time period of
three to six months. Realized and unrealized gains and losses on forward
exchange contracts that do not qualify for hedge accounting are recognized
immediately in earnings. The total gain/loss incurred for transactions which
did not qualify as hedges was a $141,000 gain for the three-month period ended
July 1, 2001 and a $315,000 loss for the six-month period ended July 1, 2001.

                                       6

   9

The Company uses forward exchange contracts to hedge net investments in certain
of its European subsidiaries as well as royalty and cost sharing payments due
the parent company. Market value gains and losses on forward contracts hedging
firm commitments are recognized when the hedged transaction occurs. These
contracts, which related primarily to the Euro currency, generally have a
maximum term of two years. Forward exchange contracts receive hedge accounting
on firmly committed transactions when they are designated as a hedge of the
designated currency exposure and are effective in minimizing such exposure.

Forward exchange contracts, that qualify for hedge accounting, with notional
amounts of $9,700,000, $6,800,000 and $1,600,000 to exchange Euros for US
dollars were outstanding as of July 1, 2001. For the three-month and six-month
periods ended July 1, 2001, the Company recorded a cumulative unrealized gain
of $555,000 and $1,909,000, respectively, related to these foreign exchange
contracts, in other comprehensive income. These amounts offset the foreign
exchange impact (the hedged transaction) which resulted in unrealized foreign
exchange losses of $565,000 and $1,838,000 for the same periods.

The market risk exposure from forward exchange contracts is assessed in light of
the underlying currency exposures and is controlled by the initiation of
additional or offsetting foreign currency contracts.

NEW PRONOUNCEMENTS

In July 2001, the Financial Accounting Standards Board (FASB) issued Statement
of Financial Accounting Standard (SFAS) No. 141, "Business Combinations." SFAS
No. 141 is effective for all business combinations initiated after June 30, 2001
and for all business combinations accounted for by the purchase method for which
the date of acquisition is after June 30, 2001. SFAS No. 141 requires that all
business combinations be accounted for under the purchase method and that
certain acquired intangible assets in a business combination be recognized as
assets apart from goodwill. The Company does not expect SFAS No. 141 to have an
impact on the Company's financial statements.

In July 2001, the FASB issued SFAS No. 142, "Goodwill and Other Intangible
Assets." SFAS No. 142 is effective for fiscal years beginning after December 15,
2001. SFAS No. 142 requires, among other things, the cessation of the
amortization of goodwill. In addition, the standard includes provisions for the
reclassification of certain existing recognized intangibles as goodwill,
reassessment of the useful lives of existing recognized intangibles,
reclassification of certain intangibles out of previously reported goodwill, and
the identification of reporting units for the purposes of assessing potential
future impairments of goodwill. SFAS No. 142 also requires the Company to
complete a transitional goodwill impairment test six months from the date of
adoption. The Company is currently assessing the impact of this new statement on
its consolidated financial position and results of operations and has not yet
determined the impact of adoption.



                                       7

   10


ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

     RESULTS OF OPERATIONS

     Revenue for the three-month and six-month periods ended July 1, 2001
     totaled $37,379,000 and $81,585,000, respectively, compared to $62,187,000
     and $116,682,000 for the same periods in 2000, representing a 40% decrease
     for the three-month period and a 30% decrease for the six-month period. The
     Company's results continue to be negatively impacted by the worldwide
     slowdown in capital equipment spending by manufacturers in the
     semiconductor and electronics industries. Sales to Original Equipment
     Manufacturers (OEM) customers, most of whom make capital equipment used by
     manufacturers in these industries, decreased $20,257,000, or 55%, from the
     three-month period in 2000 and $27,850,000, or 40%, from the six-month
     period in 2000. Sales to end-user customers decreased $4,551,000, or 18%,
     from the three-month period in 2000 and $7,247,000, or 16%, from the
     six-month period in 2000, primarily due to lower demand from customers who
     make electronic products.

     Comparing consecutive quarters, revenue decreased $6,827,000, or 15%, from
     the first quarter of 2001. Sales to OEM customers decreased $9,380,000, or
     36%, from the prior quarter. Sales to end-user customers, however,
     increased $2,553,000, or 14%, as sales to customers outside the
     high-technology industry, such as the automotive and consumer products
     industries, increased from the prior quarter.

     The Company anticipates that its results for the third quarter of 2001 will
     continue to be negatively impacted by the worldwide slowdown in capital
     equipment spending, primarily in the semiconductor and electronics
     industries. Accordingly, the Company anticipates that its revenue for the
     third quarter of 2001 will be approximately 10% lower than that reported in
     the second quarter of 2001. The Company has limited visibility to customer
     demand beyond the third quarter of 2001. The Company is continuing its
     cost-containment measures implemented earlier in 2001, including a
     restricted hiring plan and a reduction in discretionary spending.

     Gross profit as a percentage of revenue for the three-month and six-month
     periods ended July 1, 2001 was 67% and 69%, respectively, compared to 74%
     for the same periods in 2000 and 71% for the first quarter of 2001. The
     decrease in gross margin was due primarily to the impact of the lower sales
     volume and fixed manufacturing costs, as well as a greater percentage of
     revenue from the sale of services and surface inspection systems, both of
     which carry lower margins than the sale of modular vision systems. Gross
     margin is expected to continue to decrease in the third quarter of 2001 due
     to the anticipated lower revenue for that quarter compared to the prior
     quarter.

     Research, development, and engineering expenses for the three-month and
     six-month periods ended July 1, 2001 were $7,655,000 and $15,837,000,
     respectively, compared to $8,083,000 and $15,366,000 for the same periods
     in 2000, representing a 5% decrease for the three-month period and a 3%
     increase for the six-month period. Aggregate expenses were relatively flat
     with the prior year, as the impact of additional headcount to support the
     Company's continued investment in the research and development of new and
     existing products was offset by savings from cost-containment measures,
     including the elimination of all company bonuses and a reduction in
     discretionary spending. Comparing consecutive quarters, aggregate expenses
     decreased $527,000, or 6%, due to the cost-containment measures implemented
     in the first half of 2001. Expenses as a percentage of revenue were 20% and
     19% for the three-month and six-month periods in 2001, compared to 13% for
     the same periods in 2000. The increase in expenses as a percentage of
     revenue was principally due to the lower revenue base in 2001. The Company
     plans to continue its product development efforts, and therefore,
     anticipates that aggregate expenses for the remainder of 2001 will continue
     at approximately the level experienced in the second quarter.


                                       8

   11


     Selling, general, and administrative expenses for the three-month and
     six-month periods ended July 1, 2001 were $16,441,000 and $34,879,000,
     respectively, compared to $14,593,000 and $27,170,000 for the same periods
     in 2000, representing a 13% increase for the three-month period and a 28%
     increase for the six-month period. The increase in aggregate expenses was
     due primarily to the impact of additional headcount to support the
     Company's expanding worldwide operations and grow its end-user business,
     partially offset by savings from cost-containment measures, including the
     elimination of all company bonuses and a reduction in discretionary
     spending. Comparing consecutive quarters, aggregate expenses decreased
     $1,997,000, or 11%, due to the impact of the cost-containment measures
     implemented in the first half of 2001. Expenses as a percentage of revenue
     were 44% and 43% for the three-month and six-month periods in 2001,
     compared to 23% for the same periods in 2000. The increase in expenses as a
     percentage of revenue was principally due to the lower revenue base in
     2001. The Company expects to continue to realize benefits from its
     cost-containment measures, and therefore, anticipates that aggregate
     expenses for the remainder of 2001 will be lower than the level experienced
     in the second quarter.

     Amortization of goodwill for the three-month and six-month periods ended
     July 1, 2001 was $778,000 and $1,555,000, respectively, compared to
     $553,000 and $644,000 for the same periods in 2000. The increase in
     amortization expense was due to additional goodwill associated with the
     acquisitions completed during 2000.

     Investment income for the three-month and six-month periods ended July 1,
     2001 was $2,766,000 and $5,484,000 compared to $2,486,000 and $4,307,000
     for the same periods in 2000, representing an 11% and 27% increase,
     respectively. The increase in investment income was primarily due a higher
     average invested cash balance in 2001.

     The Company's effective tax rate was 32% for all periods presented.

     LIQUIDITY AND CAPITAL RESOURCES

     The Company's cash requirements during the six-month period ended July 1,
     2001 were met through cash generated from operations. Cash and investments
     increased $11,547,000 from December 31, 2000 primarily as a result of
     $14,273,000 of cash generated from operations, partially offset by
     $3,498,000 of capital expenditures, principally for computer hardware.

     On December 12, 2000, the Company's Board of Directors authorized the
     repurchase of up to $100,000,000 of the Company's common stock. As of July
     1, 2001, the Company had not repurchased any shares under this program.

     The Company believes that its existing cash and investments balance,
     together with cash generated from operations, will be sufficient to meet
     the Company's planned working capital, investing, and financing
     requirements through 2001, including the Company's stock repurchase program
     and potential business acquisitions.

     NEW PRONOUNCEMENTS

     In July 2001, the Financial Accounting Standards Board (FASB) issued
     Statement of Financial Accounting Standard (SFAS) No. 141, "Business
     Combinations." SFAS No. 141 is effective for all business combinations
     initiated after June 30, 2001 and for all business combinations accounted
     for by the purchase method for which the date of acquisition is after June
     30, 2001. SFAS No. 141 requires that all business combinations be accounted
     for under the purchase method and that certain acquired intangible assets
     in a business combination be recognized as assets apart from goodwill. The
     Company does not expect SFAS No. 141 to have an impact on the Company's
     financial statements.


                                       9

   12


     In July 2001, the FASB issued SFAS No. 142, "Goodwill and Other Intangible
     Assets." SFAS No. 142 is effective for fiscal years beginning after
     December 15, 2001. SFAS No. 142 requires, among other things, the cessation
     of the amortization of goodwill. In addition, the standard includes
     provisions for the reclassification of certain existing recognized
     intangibles as goodwill, reassessment of the useful lives of existing
     recognized intangibles, reclassification of certain intangibles out of
     previously reported goodwill, and the identification of reporting units for
     the purposes of assessing potential future impairments of goodwill. SFAS
     No. 142 also requires the Company to complete a transitional goodwill
     impairment test six months from the date of adoption. The Company is
     currently assessing the impact of this new statement on its consolidated
     financial position and results of operations and has not yet determined the
     impact of adoption.

     FORWARD-LOOKING STATEMENTS

     Certain statements made in this report, as well as oral statements made by
     the Company from time to time, which are prefaced with words such as
     "expects," "anticipates," "believes," "projects," "intends," "plans," and
     similar words and other statements of similar sense, are forward-looking
     statements. These statements are based on the Company's current
     expectations and estimates as to prospective events and circumstances,
     which may or may not be in the Company's control and as to which there can
     be no firm assurances given. These forward-looking statements, like any
     other forward-looking statements, involve risks and uncertainties that
     could cause actual results to differ materially from those projected or
     anticipated. Such risks and uncertainties include (1) the loss of, or a
     significant curtailment of purchases by, any one or more principal
     customers; (2) the cyclicality of the semiconductor and electronics
     industries; (3) the Company's continued ability to achieve significant
     international revenue; (4) the capital spending trends by manufacturing
     companies; (5) the inability to protect the Company's proprietary
     technology and intellectual property; (6) the inability to attract or
     retain skilled employees; (7) the technological obsolescence of current
     products and the inability to develop new products; (8) the inability to
     respond to competitive technology and pricing pressures; and (9) the
     reliance upon certain sole source suppliers to manufacture or deliver
     critical components of the Company's products. The foregoing list should
     not be construed as exhaustive and the Company disclaims any obligation to
     subsequently revise forward-looking statements to reflect events or
     circumstances after the date of such statements or to reflect the
     occurrence of anticipated or unanticipated events. Further discussions of
     risk factors are also available in the Company's registration statements
     filed with the Securities and Exchange Commission. The Company wishes to
     caution readers not to place undue reliance upon any such forward-looking
     statements, which speak only as of the date made.



                                       10


   13


                           PART II: OTHER INFORMATION


ITEM 1.  LEGAL PROCEEDINGS

         None

ITEM 2.  CHANGES IN SECURITIES

         None

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

         None

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         At a Special Meeting of the Stockholders of Cognex Corporation held in
         lieu of the 2001 Annual Meeting held on April 26, 2001, the
         Stockholders elected Robert J. Shillman and Anthony Sun, to serve as
         Directors for a term of three years and Patrick Alias to serve as a
         Director for a term of one year. Jerald Fishman, William Krivsky, and
         Rueben Wasserman continued as Directors after the meeting. The
         39,945,480 shares represented at the meeting voted as follows. The
         election of Robert J. Shillman as Director, 39,156,664 votes for and
         788,816 withheld; the election of Anthony Sun as Director, 39,336,626
         votes for and 608,854 withheld; the election of Patrick Alias as
         Director, 39,156,664 votes for and 788,816 withheld.


ITEM 5.  OTHER INFORMATION

         None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)   Exhibits

               None

         (b)   Reports on Form 8-K

               None


                                       11

   14


                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.




DATE:  August 14, 2001               COGNEX CORPORATION



                                     /s/ Richard A. Morin
                                     ------------------------------------------
                                     Richard A. Morin
                                     Vice President of Finance, Chief Financial
                                     Officer, and Treasurer
                                     (duly authorized officer, principal
                                     financial and accounting officer)




                                       12